Gustave Roussy, Cancer Campus, Grand Paris
4 clinical trials · 4 recruiting · OTHER
Trials by Gustave Roussy, Cancer Campus, Grand Paris
RECRUITINGNCT05691608
MoleculAr Profiling for Pediatric and Young Adult Cancer Treatment Stratification 2
FMG2025 continues the previous efforts to propose treatment for patients based on the molecular characteristics of their tumor at treatment failure in cancer precision medicine...
Sponsor: Gustave Roussy, Cancer Campus, Grand ParisEnrolling: 180020 locations
Solid TumorLeukemia
RECRUITINGPhase 2NCT05215106
Short-term Pre-OPerative Durvalumab (MEDI 4736) in Early Small Triple Negative Breast Cancer Patients (POP-Durva)
This study aims to evaluate the efficacy and safety of preoperative Durvalumab in patients with early small (cT1N0) triple negative breast cancer tumors. This study will recruit...
Sponsor: Gustave Roussy, Cancer Campus, Grand ParisEnrolling: 2003 locations
Early Small (cT1N0) Triple Negative Breast Cancer
RECRUITINGNCT06907095
Cohort Evaluation of Body Fluids Early Detection of Cancer in High-risk Individuals
LEAH is a prospective, observational, single-centre, non-randomised, open-label study of people at increased risk of cancer or malignant disease. The main objective of LEAH is to...
Sponsor: Gustave Roussy, Cancer Campus, Grand ParisEnrolling: 59091 location
Risk of Breast CancerRisk of Gynaecological CancerRisk of Colorectal Cancer+14
RECRUITINGPhase 4NCT06934057
Cabozantinib and Nivolumab Among Older Patients With Renal Cell Carcinoma
The goal of the study is to describe real-life use and exposition to nivolumab-cabozantinib among older patients with metastatic clear-cell renal cell cancer
Sponsor: Gustave Roussy, Cancer Campus, Grand ParisEnrolling: 507 locations
Kidney CancerRenal Cell Cancer